Blood metabolites reflect the effect of gut microbiota on differentiated thyroid cancer: a Mendelian randomization analysis
Background Studies have linked gut microbiome and differentiated thyroid cancer (DTC). However, their causal relationships and potential mediating factors have not been well defined. Our study investigated the causal relationships between the gut microbiome, papillary thyroid cancer (PTC) and follic...
Saved in:
| Published in: | BMC cancer Vol. 25; no. 1; pp. 368 - 10 |
|---|---|
| Main Authors: | , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
London
BioMed Central
28.02.2025
BioMed Central Ltd Springer Nature B.V BMC |
| Subjects: | |
| ISSN: | 1471-2407, 1471-2407 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Background
Studies have linked gut microbiome and differentiated thyroid cancer (DTC). However, their causal relationships and potential mediating factors have not been well defined. Our study investigated the causal relationships between the gut microbiome, papillary thyroid cancer (PTC) and follicular thyroid cancer (FTC), as well as the mediating effect of potential blood metabolites, using genetic approaches.
Methods
Leveraging the summary statistics of gut microbial taxa, blood metabolites, PTC and FTC from the largest genome-wide association studies (GWAS) to date, we applied the bidirectional and mediation Mendelian randomization (MR) design. The multivariable MR approach based on Bayesian model averaging (MR-BMA) was used to prioritize the most likely causal taxa. Furthermore, metabolic pathway analysis was performed via the web-based Metaconflict 4.0.
Results
After sensitivity analyses, we identified 4 taxa, 19 blood metabolites, and 5 gut bacterial pathways were causally associated with PTC. Similarly, 3 taxa, 31 blood metabolites, and 3 gut bacterial pathways were found to be causally associated with FTC, with 2 blood metabolites exhibiting bidirectional causal relationships. Metabolic pathway analysis revealed 8 significant pathways in PTC and FTC. MR-BMA analysis pinpointed species
Bifidobacterium longum
as the primary causal taxon for PTC and genus
Bacteroides
for FTC. The mediation MR analysis showed that sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) and 2-hydroxysebacate mediated the causal effects of specific gut microbiota on PTC and FTC, respectively.
Conclusion
The study suggested a causal relationship between several gut microbial taxa and DTC, and that specific blood metabolites might mediate this relationship. |
|---|---|
| AbstractList | Background Studies have linked gut microbiome and differentiated thyroid cancer (DTC). However, their causal relationships and potential mediating factors have not been well defined. Our study investigated the causal relationships between the gut microbiome, papillary thyroid cancer (PTC) and follicular thyroid cancer (FTC), as well as the mediating effect of potential blood metabolites, using genetic approaches. Methods Leveraging the summary statistics of gut microbial taxa, blood metabolites, PTC and FTC from the largest genome-wide association studies (GWAS) to date, we applied the bidirectional and mediation Mendelian randomization (MR) design. The multivariable MR approach based on Bayesian model averaging (MR-BMA) was used to prioritize the most likely causal taxa. Furthermore, metabolic pathway analysis was performed via the web-based Metaconflict 4.0. Results After sensitivity analyses, we identified 4 taxa, 19 blood metabolites, and 5 gut bacterial pathways were causally associated with PTC. Similarly, 3 taxa, 31 blood metabolites, and 3 gut bacterial pathways were found to be causally associated with FTC, with 2 blood metabolites exhibiting bidirectional causal relationships. Metabolic pathway analysis revealed 8 significant pathways in PTC and FTC. MR-BMA analysis pinpointed species Bifidobacterium longum as the primary causal taxon for PTC and genus Bacteroides for FTC. The mediation MR analysis showed that sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) and 2-hydroxysebacate mediated the causal effects of specific gut microbiota on PTC and FTC, respectively. Conclusion The study suggested a causal relationship between several gut microbial taxa and DTC, and that specific blood metabolites might mediate this relationship. Keywords: Papillary thyroid cancer, Follicular thyroid cancer, Blood metabolites, Gut Microbiota, Mendelian randomization Studies have linked gut microbiome and differentiated thyroid cancer (DTC). However, their causal relationships and potential mediating factors have not been well defined. Our study investigated the causal relationships between the gut microbiome, papillary thyroid cancer (PTC) and follicular thyroid cancer (FTC), as well as the mediating effect of potential blood metabolites, using genetic approaches. Leveraging the summary statistics of gut microbial taxa, blood metabolites, PTC and FTC from the largest genome-wide association studies (GWAS) to date, we applied the bidirectional and mediation Mendelian randomization (MR) design. The multivariable MR approach based on Bayesian model averaging (MR-BMA) was used to prioritize the most likely causal taxa. Furthermore, metabolic pathway analysis was performed via the web-based Metaconflict 4.0. After sensitivity analyses, we identified 4 taxa, 19 blood metabolites, and 5 gut bacterial pathways were causally associated with PTC. Similarly, 3 taxa, 31 blood metabolites, and 3 gut bacterial pathways were found to be causally associated with FTC, with 2 blood metabolites exhibiting bidirectional causal relationships. Metabolic pathway analysis revealed 8 significant pathways in PTC and FTC. MR-BMA analysis pinpointed species Bifidobacterium longum as the primary causal taxon for PTC and genus Bacteroides for FTC. The mediation MR analysis showed that sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) and 2-hydroxysebacate mediated the causal effects of specific gut microbiota on PTC and FTC, respectively. The study suggested a causal relationship between several gut microbial taxa and DTC, and that specific blood metabolites might mediate this relationship. Background Studies have linked gut microbiome and differentiated thyroid cancer (DTC). However, their causal relationships and potential mediating factors have not been well defined. Our study investigated the causal relationships between the gut microbiome, papillary thyroid cancer (PTC) and follicular thyroid cancer (FTC), as well as the mediating effect of potential blood metabolites, using genetic approaches. Methods Leveraging the summary statistics of gut microbial taxa, blood metabolites, PTC and FTC from the largest genome-wide association studies (GWAS) to date, we applied the bidirectional and mediation Mendelian randomization (MR) design. The multivariable MR approach based on Bayesian model averaging (MR-BMA) was used to prioritize the most likely causal taxa. Furthermore, metabolic pathway analysis was performed via the web-based Metaconflict 4.0. Results After sensitivity analyses, we identified 4 taxa, 19 blood metabolites, and 5 gut bacterial pathways were causally associated with PTC. Similarly, 3 taxa, 31 blood metabolites, and 3 gut bacterial pathways were found to be causally associated with FTC, with 2 blood metabolites exhibiting bidirectional causal relationships. Metabolic pathway analysis revealed 8 significant pathways in PTC and FTC. MR-BMA analysis pinpointed species Bifidobacterium longum as the primary causal taxon for PTC and genus Bacteroides for FTC. The mediation MR analysis showed that sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) and 2-hydroxysebacate mediated the causal effects of specific gut microbiota on PTC and FTC, respectively. Conclusion The study suggested a causal relationship between several gut microbial taxa and DTC, and that specific blood metabolites might mediate this relationship. Abstract Background Studies have linked gut microbiome and differentiated thyroid cancer (DTC). However, their causal relationships and potential mediating factors have not been well defined. Our study investigated the causal relationships between the gut microbiome, papillary thyroid cancer (PTC) and follicular thyroid cancer (FTC), as well as the mediating effect of potential blood metabolites, using genetic approaches. Methods Leveraging the summary statistics of gut microbial taxa, blood metabolites, PTC and FTC from the largest genome-wide association studies (GWAS) to date, we applied the bidirectional and mediation Mendelian randomization (MR) design. The multivariable MR approach based on Bayesian model averaging (MR-BMA) was used to prioritize the most likely causal taxa. Furthermore, metabolic pathway analysis was performed via the web-based Metaconflict 4.0. Results After sensitivity analyses, we identified 4 taxa, 19 blood metabolites, and 5 gut bacterial pathways were causally associated with PTC. Similarly, 3 taxa, 31 blood metabolites, and 3 gut bacterial pathways were found to be causally associated with FTC, with 2 blood metabolites exhibiting bidirectional causal relationships. Metabolic pathway analysis revealed 8 significant pathways in PTC and FTC. MR-BMA analysis pinpointed species Bifidobacterium longum as the primary causal taxon for PTC and genus Bacteroides for FTC. The mediation MR analysis showed that sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) and 2-hydroxysebacate mediated the causal effects of specific gut microbiota on PTC and FTC, respectively. Conclusion The study suggested a causal relationship between several gut microbial taxa and DTC, and that specific blood metabolites might mediate this relationship. Studies have linked gut microbiome and differentiated thyroid cancer (DTC). However, their causal relationships and potential mediating factors have not been well defined. Our study investigated the causal relationships between the gut microbiome, papillary thyroid cancer (PTC) and follicular thyroid cancer (FTC), as well as the mediating effect of potential blood metabolites, using genetic approaches.BACKGROUNDStudies have linked gut microbiome and differentiated thyroid cancer (DTC). However, their causal relationships and potential mediating factors have not been well defined. Our study investigated the causal relationships between the gut microbiome, papillary thyroid cancer (PTC) and follicular thyroid cancer (FTC), as well as the mediating effect of potential blood metabolites, using genetic approaches.Leveraging the summary statistics of gut microbial taxa, blood metabolites, PTC and FTC from the largest genome-wide association studies (GWAS) to date, we applied the bidirectional and mediation Mendelian randomization (MR) design. The multivariable MR approach based on Bayesian model averaging (MR-BMA) was used to prioritize the most likely causal taxa. Furthermore, metabolic pathway analysis was performed via the web-based Metaconflict 4.0.METHODSLeveraging the summary statistics of gut microbial taxa, blood metabolites, PTC and FTC from the largest genome-wide association studies (GWAS) to date, we applied the bidirectional and mediation Mendelian randomization (MR) design. The multivariable MR approach based on Bayesian model averaging (MR-BMA) was used to prioritize the most likely causal taxa. Furthermore, metabolic pathway analysis was performed via the web-based Metaconflict 4.0.After sensitivity analyses, we identified 4 taxa, 19 blood metabolites, and 5 gut bacterial pathways were causally associated with PTC. Similarly, 3 taxa, 31 blood metabolites, and 3 gut bacterial pathways were found to be causally associated with FTC, with 2 blood metabolites exhibiting bidirectional causal relationships. Metabolic pathway analysis revealed 8 significant pathways in PTC and FTC. MR-BMA analysis pinpointed species Bifidobacterium longum as the primary causal taxon for PTC and genus Bacteroides for FTC. The mediation MR analysis showed that sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) and 2-hydroxysebacate mediated the causal effects of specific gut microbiota on PTC and FTC, respectively.RESULTSAfter sensitivity analyses, we identified 4 taxa, 19 blood metabolites, and 5 gut bacterial pathways were causally associated with PTC. Similarly, 3 taxa, 31 blood metabolites, and 3 gut bacterial pathways were found to be causally associated with FTC, with 2 blood metabolites exhibiting bidirectional causal relationships. Metabolic pathway analysis revealed 8 significant pathways in PTC and FTC. MR-BMA analysis pinpointed species Bifidobacterium longum as the primary causal taxon for PTC and genus Bacteroides for FTC. The mediation MR analysis showed that sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) and 2-hydroxysebacate mediated the causal effects of specific gut microbiota on PTC and FTC, respectively.The study suggested a causal relationship between several gut microbial taxa and DTC, and that specific blood metabolites might mediate this relationship.CONCLUSIONThe study suggested a causal relationship between several gut microbial taxa and DTC, and that specific blood metabolites might mediate this relationship. BackgroundStudies have linked gut microbiome and differentiated thyroid cancer (DTC). However, their causal relationships and potential mediating factors have not been well defined. Our study investigated the causal relationships between the gut microbiome, papillary thyroid cancer (PTC) and follicular thyroid cancer (FTC), as well as the mediating effect of potential blood metabolites, using genetic approaches.MethodsLeveraging the summary statistics of gut microbial taxa, blood metabolites, PTC and FTC from the largest genome-wide association studies (GWAS) to date, we applied the bidirectional and mediation Mendelian randomization (MR) design. The multivariable MR approach based on Bayesian model averaging (MR-BMA) was used to prioritize the most likely causal taxa. Furthermore, metabolic pathway analysis was performed via the web-based Metaconflict 4.0.ResultsAfter sensitivity analyses, we identified 4 taxa, 19 blood metabolites, and 5 gut bacterial pathways were causally associated with PTC. Similarly, 3 taxa, 31 blood metabolites, and 3 gut bacterial pathways were found to be causally associated with FTC, with 2 blood metabolites exhibiting bidirectional causal relationships. Metabolic pathway analysis revealed 8 significant pathways in PTC and FTC. MR-BMA analysis pinpointed species Bifidobacterium longum as the primary causal taxon for PTC and genus Bacteroides for FTC. The mediation MR analysis showed that sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) and 2-hydroxysebacate mediated the causal effects of specific gut microbiota on PTC and FTC, respectively.ConclusionThe study suggested a causal relationship between several gut microbial taxa and DTC, and that specific blood metabolites might mediate this relationship. Studies have linked gut microbiome and differentiated thyroid cancer (DTC). However, their causal relationships and potential mediating factors have not been well defined. Our study investigated the causal relationships between the gut microbiome, papillary thyroid cancer (PTC) and follicular thyroid cancer (FTC), as well as the mediating effect of potential blood metabolites, using genetic approaches. Leveraging the summary statistics of gut microbial taxa, blood metabolites, PTC and FTC from the largest genome-wide association studies (GWAS) to date, we applied the bidirectional and mediation Mendelian randomization (MR) design. The multivariable MR approach based on Bayesian model averaging (MR-BMA) was used to prioritize the most likely causal taxa. Furthermore, metabolic pathway analysis was performed via the web-based Metaconflict 4.0. After sensitivity analyses, we identified 4 taxa, 19 blood metabolites, and 5 gut bacterial pathways were causally associated with PTC. Similarly, 3 taxa, 31 blood metabolites, and 3 gut bacterial pathways were found to be causally associated with FTC, with 2 blood metabolites exhibiting bidirectional causal relationships. Metabolic pathway analysis revealed 8 significant pathways in PTC and FTC. MR-BMA analysis pinpointed species Bifidobacterium longum as the primary causal taxon for PTC and genus Bacteroides for FTC. The mediation MR analysis showed that sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) and 2-hydroxysebacate mediated the causal effects of specific gut microbiota on PTC and FTC, respectively. The study suggested a causal relationship between several gut microbial taxa and DTC, and that specific blood metabolites might mediate this relationship. |
| ArticleNumber | 368 |
| Audience | Academic |
| Author | Zhang, Hanfei Li, Lin Li, Yuhao |
| Author_xml | – sequence: 1 givenname: Hanfei surname: Zhang fullname: Zhang, Hanfei organization: Department of Nuclear Medicine, West China Hospital, Sichuan University – sequence: 2 givenname: Yuhao surname: Li fullname: Li, Yuhao organization: Department of Nuclear Medicine, West China Hospital, Sichuan University – sequence: 3 givenname: Lin orcidid: 0000-0001-8349-9588 surname: Li fullname: Li, Lin email: lilinhuaxi@sina.com organization: Department of Nuclear Medicine, West China Hospital, Sichuan University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40022019$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9ktuKFDEQhhtZcQ_6Al5IgyB60WuS7nS6vVsXDwMrgofrUEkqM1m6O2uSBkdf3szMus6ISC4Sqr6_QlX9p8XR5CcsiseUnFPatS8jZV3HK8J4RWved9X6XnFCG0Er1hBxtPc-Lk5jvCaEio50D4rjhhDGCO1Pip-vB-9NOWIC5QeXMJYB7YA6lWmFJVq7eXpbLudUjk4Hr5xPUPqpNC4nA07JQUKT8XXwzpQaJo3hVQnlB5wMDg6mMsBk_Oh-QHJZCBMM6-jiw-K-hSHio9v7rPj69s2Xy_fV1cd3i8uLq0rztkuVVgp6VJQZy5QBMK2pOytaAVjnFBrDhKEMiDaC9DUqYIobqgxn3Fpq67NisatrPFzLm-BGCGvpwcltwIelhJCcHlAKboVhqDStbYN12zXUdKJRmuuaKCFyree7WjfBf5sxJjm6qHEYYEI_R1lTwYQQvOMZffoXeu3nkHvfUrwhtKn3qCXk_91kfQqgN0XlRcd6xpuW95k6_weVj8G8lGwL63L8QPDiQJCZhN_TEuYY5eLzp0P22R67QhjSKvph3iwrHoJPbjua1YjmbpS_7ZQBtgOyT2LMRrpDKJEbz8qdZ2X2rNx6Vq6zqN6JYoanJYY_c_qP6hfS7e5z |
| Cites_doi | 10.1210/jc.2007-0606 10.1080/17474124.2022.2064273 10.1007/978-1-0716-0239-3_17 10.1038/nature15394 10.1038/s41588-018-0099-7 10.1016/j.canlet.2021.10.002 10.1111/cen.13437 10.18632/oncotarget.11603 10.3389/fendo.2022.893164 10.1210/endocr/bqad184 10.1080/19490976.2023.2282795 10.1007/s00284-014-0640-6 10.1021/acs.chemrev.2c00431 10.1093/femsre/fuu010 10.3389/fgene.2023.1299930 10.1093/eurjpc/zwad171 10.1007/s11523-021-00861-y 10.1080/01635589109514163 10.1038/nrc.2017.96 10.1038/s41569-022-00771-0 10.1038/srep14869 10.1007/s00432-023-05535-y 10.1093/carcin/18.4.833 10.18632/oncotarget.9124 10.1002/ijc.32007 10.1016/j.jchromb.2017.10.004 10.4158/EP15844.OR 10.1016/j.tem.2019.05.008 10.1016/j.semcancer.2021.09.007 10.1038/s41467-019-13870-3 10.1016/j.chom.2013.07.007 10.1039/c1mb05029j 10.1016/j.jare.2021.04.001 10.1055/s-0035-1559631 10.3390/nu15122680 10.1007/s13311-017-0600-5 10.1038/nrm2329 10.1038/s42003-021-02587-z 10.7150/jca.66816 10.1097/MOL.0000000000000308 10.3389/fmolb.2022.1039121 10.1093/ije/dyr036 10.3390/metabo11090614 10.1016/j.yexcr.2017.07.009 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2025 2025. The Author(s). COPYRIGHT 2025 BioMed Central Ltd. 2025. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2025 – notice: 2025. The Author(s). – notice: COPYRIGHT 2025 BioMed Central Ltd. – notice: 2025. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7TO 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 DOA |
| DOI | 10.1186/s12885-025-13598-y |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: ProQuest Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Statistics |
| EISSN | 1471-2407 |
| EndPage | 10 |
| ExternalDocumentID | oai_doaj_org_article_75f7d2ebc13f4e36841d874bc5c30b77 A829254659 40022019 10_1186_s12885_025_13598_y |
| Genre | Journal Article |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GrantInformation_xml | – fundername: West China Hospital, Sichuan University grantid: ZYGD23016 funderid: http://dx.doi.org/10.13039/501100013365 – fundername: West China Hospital, Sichuan University grantid: ZYGD23016 |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR ISR ITC KQ8 LGEZI LOTEE M1P M48 M~E NADUK NXXTH O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB AAYXX AFFHD CITATION ALIPV CGR CUY CVF ECM EIF NPM 3V. 7TO 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI PRINS 7X8 |
| ID | FETCH-LOGICAL-c568t-cbba9eb12df2bdaad6d38f767ae3bbaedd27d12a0cd7093eba2b5d1bd525ff1f3 |
| IEDL.DBID | BENPR |
| ISICitedReferencesCount | 3 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001435005600003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1471-2407 |
| IngestDate | Fri Oct 03 12:53:03 EDT 2025 Sun Nov 09 12:19:19 EST 2025 Sat Nov 29 14:32:24 EST 2025 Tue Nov 11 10:52:10 EST 2025 Tue Nov 04 18:13:20 EST 2025 Thu Nov 13 15:59:22 EST 2025 Thu May 22 21:23:47 EDT 2025 Mon May 12 02:38:46 EDT 2025 Sat Nov 29 08:16:28 EST 2025 Sat Sep 06 07:29:01 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Mendelian randomization Papillary thyroid cancer Follicular thyroid cancer Gut Microbiota Blood metabolites |
| Language | English |
| License | 2025. The Author(s). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c568t-cbba9eb12df2bdaad6d38f767ae3bbaedd27d12a0cd7093eba2b5d1bd525ff1f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0001-8349-9588 |
| OpenAccessLink | https://www.proquest.com/docview/3175401435?pq-origsite=%requestingapplication% |
| PMID | 40022019 |
| PQID | 3175401435 |
| PQPubID | 44074 |
| PageCount | 10 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_75f7d2ebc13f4e36841d874bc5c30b77 proquest_miscellaneous_3172777585 proquest_journals_3175401435 gale_infotracmisc_A829254659 gale_infotracacademiconefile_A829254659 gale_incontextgauss_ISR_A829254659 gale_healthsolutions_A829254659 pubmed_primary_40022019 crossref_primary_10_1186_s12885_025_13598_y springer_journals_10_1186_s12885_025_13598_y |
| PublicationCentury | 2000 |
| PublicationDate | 2025-02-28 |
| PublicationDateYYYYMMDD | 2025-02-28 |
| PublicationDate_xml | – month: 02 year: 2025 text: 2025-02-28 day: 28 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC cancer |
| PublicationTitleAbbrev | BMC Cancer |
| PublicationTitleAlternate | BMC Cancer |
| PublicationYear | 2025 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | J Zhou (13598_CR16) 2024; 150 A Rizzo (13598_CR4) 2022; 16 V Zuber (13598_CR23) 2020; 11 A Fernandes (13598_CR1) 2023; 15 V Mollica (13598_CR3) 2022; 17 CT Shen (13598_CR10) 2017; 87 Z Yao (13598_CR11) 2011; 7 PH Sudmant (13598_CR20) 2015; 526 RM Chakaroun (13598_CR45) 2023; 20 Y Rong (13598_CR32) 2017; 358 E Fröhlich (13598_CR8) 2019; 30 X Chen (13598_CR40) 2016; 7 M Koo (13598_CR30) 1991; 16 B Ogretmen (13598_CR36) 2018; 18 T Hou (13598_CR17) 2023; 165 H Dai (13598_CR19) 2023; 30 J Li (13598_CR41) 2017; 8 YA Hannun (13598_CR35) 2008; 9 J Singh (13598_CR31) 1997; 18 HM Ishaq (13598_CR33) 2022; 13 EC Lauritano (13598_CR6) 2007; 92 G Lu (13598_CR43) 2022; 13 L Zhou (13598_CR9) 2014; 69 G Cui (13598_CR46) 2023; 15 LH Duntas (13598_CR26) 2015; 47 H Neuman (13598_CR29) 2015; 39 D Huo (13598_CR25) 2021; 4 A Rizzo (13598_CR2) 2022; 86 AD Kostic (13598_CR7) 2013; 14 DQY Quek (13598_CR38) 2021; 11 DC Guven (13598_CR5) 2022; 9 S Burgess (13598_CR21) 2011; 40 Z Wang (13598_CR39) 2016; 27 X Yu (13598_CR14) 2022; 35 X Shao (13598_CR34) 2021; 523 J Chong (13598_CR24) 2020; 2104 R Farrokhi Yekta (13598_CR13) 2017; 22 N Aggarwal (13598_CR44) 2023; 123 SI Do (13598_CR37) 2017; 37 Y Tian (13598_CR12) 2015; 5 S Shen (13598_CR42) 2017; 1068–1069 A Farzi (13598_CR28) 2018; 15 J Feng (13598_CR15) 2019; 144 M Verbanck (13598_CR22) 2018; 50 Y Song (13598_CR27) 2016; 22 Z Quan (13598_CR18) 2023; 14 |
| References_xml | – volume: 92 start-page: 4180 issue: 11 year: 2007 ident: 13598_CR6 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2007-0606 – volume: 16 start-page: 333 issue: 4 year: 2022 ident: 13598_CR4 publication-title: Expert Rev Gastroenterol Hepatol doi: 10.1080/17474124.2022.2064273 – volume: 2104 start-page: 337 year: 2020 ident: 13598_CR24 publication-title: Methods Mol Biol. doi: 10.1007/978-1-0716-0239-3_17 – volume: 526 start-page: 75 issue: 7571 year: 2015 ident: 13598_CR20 publication-title: Nature doi: 10.1038/nature15394 – volume: 50 start-page: 693 issue: 5 year: 2018 ident: 13598_CR22 publication-title: Nat Genet doi: 10.1038/s41588-018-0099-7 – volume: 523 start-page: 170 year: 2021 ident: 13598_CR34 publication-title: Cancer Lett doi: 10.1016/j.canlet.2021.10.002 – volume: 87 start-page: 844 issue: 6 year: 2017 ident: 13598_CR10 publication-title: Clin Endocrinol (Oxf) doi: 10.1111/cen.13437 – volume: 8 start-page: 46834 issue: 29 year: 2017 ident: 13598_CR41 publication-title: Oncotarget doi: 10.18632/oncotarget.11603 – volume: 13 start-page: 893164 year: 2022 ident: 13598_CR43 publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2022.893164 – volume: 165 start-page: bqad184 issue: 1 year: 2023 ident: 13598_CR17 publication-title: Endocrinology. doi: 10.1210/endocr/bqad184 – volume: 15 start-page: 2282795 issue: 2 year: 2023 ident: 13598_CR46 publication-title: Gut Microbes doi: 10.1080/19490976.2023.2282795 – volume: 69 start-page: 675 issue: 5 year: 2014 ident: 13598_CR9 publication-title: Curr Microbiol doi: 10.1007/s00284-014-0640-6 – volume: 123 start-page: 31 issue: 1 year: 2023 ident: 13598_CR44 publication-title: Chem Rev doi: 10.1021/acs.chemrev.2c00431 – volume: 39 start-page: 509 issue: 4 year: 2015 ident: 13598_CR29 publication-title: FEMS Microbiol Rev doi: 10.1093/femsre/fuu010 – volume: 22 start-page: 595 issue: 7 year: 2017 ident: 13598_CR13 publication-title: Biomarkers – volume: 14 start-page: 1299930 year: 2023 ident: 13598_CR18 publication-title: Front Genet doi: 10.3389/fgene.2023.1299930 – volume: 30 start-page: 1274 issue: 12 year: 2023 ident: 13598_CR19 publication-title: Eur J Prev Cardiol doi: 10.1093/eurjpc/zwad171 – volume: 17 start-page: 61 issue: 1 year: 2022 ident: 13598_CR3 publication-title: Target Oncol doi: 10.1007/s11523-021-00861-y – volume: 16 start-page: 249 issue: 3–4 year: 1991 ident: 13598_CR30 publication-title: Nutr Cancer doi: 10.1080/01635589109514163 – volume: 18 start-page: 33 issue: 1 year: 2018 ident: 13598_CR36 publication-title: Nat Rev Cancer doi: 10.1038/nrc.2017.96 – volume: 20 start-page: 217 issue: 4 year: 2023 ident: 13598_CR45 publication-title: Nat Rev Cardiol doi: 10.1038/s41569-022-00771-0 – volume: 5 start-page: 14869 year: 2015 ident: 13598_CR12 publication-title: Sci Rep doi: 10.1038/srep14869 – volume: 150 start-page: 75 issue: 2 year: 2024 ident: 13598_CR16 publication-title: J Cancer Res Clin Oncol doi: 10.1007/s00432-023-05535-y – volume: 18 start-page: 833 issue: 4 year: 1997 ident: 13598_CR31 publication-title: Carcinogenesis doi: 10.1093/carcin/18.4.833 – volume: 7 start-page: 36622 issue: 24 year: 2016 ident: 13598_CR40 publication-title: Oncotarget doi: 10.18632/oncotarget.9124 – volume: 144 start-page: 2728 issue: 11 year: 2019 ident: 13598_CR15 publication-title: Int J Cancer doi: 10.1002/ijc.32007 – volume: 1068–1069 start-page: 41 year: 2017 ident: 13598_CR42 publication-title: J Chromatogr B Analyt Technol Biomed Life Sci doi: 10.1016/j.jchromb.2017.10.004 – volume: 22 start-page: 420 issue: 4 year: 2016 ident: 13598_CR27 publication-title: Endocr Pract doi: 10.4158/EP15844.OR – volume: 30 start-page: 479 issue: 8 year: 2019 ident: 13598_CR8 publication-title: Trends Endocrinol Metab doi: 10.1016/j.tem.2019.05.008 – volume: 86 start-page: 1058 issue: Pt 3 year: 2022 ident: 13598_CR2 publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2021.09.007 – volume: 11 start-page: 29 issue: 1 year: 2020 ident: 13598_CR23 publication-title: Nat Commun doi: 10.1038/s41467-019-13870-3 – volume: 37 start-page: 5399 issue: 10 year: 2017 ident: 13598_CR37 publication-title: Anticancer Res – volume: 14 start-page: 207 issue: 2 year: 2013 ident: 13598_CR7 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2013.07.007 – volume: 7 start-page: 2608 issue: 9 year: 2011 ident: 13598_CR11 publication-title: Mol Biosyst doi: 10.1039/c1mb05029j – volume: 35 start-page: 61 year: 2022 ident: 13598_CR14 publication-title: J Adv Res doi: 10.1016/j.jare.2021.04.001 – volume: 47 start-page: 721 issue: 10 year: 2015 ident: 13598_CR26 publication-title: Horm Metab Res doi: 10.1055/s-0035-1559631 – volume: 15 start-page: 2680 issue: 12 year: 2023 ident: 13598_CR1 publication-title: Nutrients. doi: 10.3390/nu15122680 – volume: 15 start-page: 5 issue: 1 year: 2018 ident: 13598_CR28 publication-title: Neurotherapeutics doi: 10.1007/s13311-017-0600-5 – volume: 9 start-page: 139 issue: 2 year: 2008 ident: 13598_CR35 publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm2329 – volume: 4 start-page: 1046 issue: 1 year: 2021 ident: 13598_CR25 publication-title: Commun Biol doi: 10.1038/s42003-021-02587-z – volume: 13 start-page: 2014 issue: 6 year: 2022 ident: 13598_CR33 publication-title: J Cancer doi: 10.7150/jca.66816 – volume: 27 start-page: 216 issue: 3 year: 2016 ident: 13598_CR39 publication-title: Curr Opin Lipidol doi: 10.1097/MOL.0000000000000308 – volume: 9 start-page: 1039121 year: 2022 ident: 13598_CR5 publication-title: Front Mol Biosci doi: 10.3389/fmolb.2022.1039121 – volume: 40 start-page: 755 issue: 3 year: 2011 ident: 13598_CR21 publication-title: Int J Epidemiol doi: 10.1093/ije/dyr036 – volume: 11 start-page: 614 issue: 9 year: 2021 ident: 13598_CR38 publication-title: Metabolites. doi: 10.3390/metabo11090614 – volume: 358 start-page: 352 issue: 2 year: 2017 ident: 13598_CR32 publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2017.07.009 |
| SSID | ssj0017808 |
| Score | 2.4549563 |
| Snippet | Background
Studies have linked gut microbiome and differentiated thyroid cancer (DTC). However, their causal relationships and potential mediating factors have... Studies have linked gut microbiome and differentiated thyroid cancer (DTC). However, their causal relationships and potential mediating factors have not been... Background Studies have linked gut microbiome and differentiated thyroid cancer (DTC). However, their causal relationships and potential mediating factors have... BackgroundStudies have linked gut microbiome and differentiated thyroid cancer (DTC). However, their causal relationships and potential mediating factors have... Abstract Background Studies have linked gut microbiome and differentiated thyroid cancer (DTC). However, their causal relationships and potential mediating... |
| SourceID | doaj proquest gale pubmed crossref springer |
| SourceType | Open Website Aggregation Database Index Database Publisher |
| StartPage | 368 |
| SubjectTerms | Adenocarcinoma, Follicular - blood Adenocarcinoma, Follicular - genetics Adenocarcinoma, Follicular - microbiology Adenocarcinoma, Follicular - pathology Bayes Theorem Bayesian analysis Biomedical and Life Sciences Biomedicine Blood Blood metabolites Cancer Research Causes of Development and progression Follicular thyroid cancer Gastrointestinal Microbiome Gastrointestinal system Genome-wide association studies Genome-Wide Association Study Genomes Gut Microbiota Health aspects Health Promotion and Disease Prevention Humans Intestinal microflora Medicine/Public Health Mendelian randomization Mendelian Randomization Analysis Metabolic Networks and Pathways Metabolic pathways Metabolism Metabolites Microbiomes Microbiota Microbiota (Symbiotic organisms) Oncology Papillary thyroid cancer Physiological aspects Sensitivity analysis Sphingomyelin Statistical analysis Statistics Surgical Oncology Thyroid cancer Thyroid Cancer, Papillary - blood Thyroid Cancer, Papillary - genetics Thyroid Cancer, Papillary - microbiology Thyroid Cancer, Papillary - pathology Thyroid Neoplasms - blood Thyroid Neoplasms - genetics Thyroid Neoplasms - microbiology Thyroid Neoplasms - pathology |
| SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQhRAXxJvQAgYhcYCoiZ3EDrcWUcGhFeIh9Wb5We1hE5RkkVb988w4ydKAEBeu69lkd17-bM98JuSlgegrBUSas46nBXMaQsqElHPLtOGR5C1eNiHOzuT5ef3pylVfWBM20gOPijsUZRCOeWNzHgrPK1nkTorC2NLyzIjYRw6oZ15MTecHQmZybpGR1WEPWVhiJ3KZ5khZl24X01Bk6_8zJ1-ZlH47JY2Tz8ltcmtCjfRo_LV3yDXf3CU3Tqdz8Xvk8hjrz-naD2BT7CruKbwSd-QpADw6Fm3QNtCLzUDXq5F8adC0beh8QwpEOoBPEN927cpRi97QvaWanuImOW6GUJjWXLueGjepnuhM7pNvJ--_vvuQTtcqpLas5JBaY3QNKZq5wIzT2lWOyyAqoT2HIe8cEy5nOrNOZDX3RjNTuty4kpUh5IE_IHtN2_hHhNYuswEAFGSqqgBkoX3mEFDAIqZmVhcJeT1rWX0f2TNUXHXISo02UWATFW2itgk5RkPsJJH5On4A_qAmf1D_8oeEPEMzqrGNdBe_6kiyGrn_yzohL6IEsl80WF5zoTd9rz5--bwQejUJhXbotNVTtwL8byTMWkgeLCQhPO1yePYnNaWHXiFoK5BZsUzI890wfhNL3hrfbqIMEwKXcwl5OPrhTjMFQi8A5wl5Mzvmr4f_XcGP_4eC98lNhoEU2_oPyN7QbfwTct3-GFZ99zSG4U_P4zXG priority: 102 providerName: Directory of Open Access Journals – databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagIMSF9yNQwCAkDjQisZPY4dYiKji0Qi2g3iw_Vz1sgpIs0oo_z4yTLCyPA1zXkyg7nsdne-YzIc8NeF8pwNOcdTwtmNPgUiaknFumDY8kb_GyCXF8LM_O6g9TU1g_V7vPR5IxUke3ltWrHiKpxG7iMs2Rdi5dXySXIN1JdMeT08-bswMhMzm3x_zxua0UFJn6f4_HPyWkX05IY-I5vP5_n3yDXJuAJt0fLeMmueCbW-TK0XSUfpt8O8CSdbr0A5gBNiL3FL4UN_EpYEI61nnQNtDFaqDL85GvadC0beh8qQoEB8CrIL7u2nNHLRpQ95pqeoT76rh_QiETunY59XpSPTGg3CGfDt9-fPMunW5iSG1ZySG1xugaojpzgRmntascl0FUQnsOQ945JlzOdGadyGrujWamdLlxJStDyAO_S3aatvH3Ca1dZgNgLghuVQFgRPvMIQaBdU_NrC4S8nKeHPVlJNxQcaEiKzXqU4E-VdSnWifkAOdvI4lk2fGHtluoyfeUKINwzBub81B4Xskid1IUxpaWZ0aIhDzB2Vdj5-nG5dW-ZDVeF1DWCXkWJZAwo8GKnIVe9b16f3qyJfRiEgrt0GmrpwYH-N_IsbUlubslCR5tt4dnM1RTROkV4rwCyRjLhDzdDOOTWCXX-HYVZZgQuAJMyL3RfDeaKRCtAZ5PyN5sqz9e_ncFP_g38YfkKkNzjz3_u2Rn6Fb-Eblsvw7nffc4-ul3WE46zg priority: 102 providerName: Springer Nature |
| Title | Blood metabolites reflect the effect of gut microbiota on differentiated thyroid cancer: a Mendelian randomization analysis |
| URI | https://link.springer.com/article/10.1186/s12885-025-13598-y https://www.ncbi.nlm.nih.gov/pubmed/40022019 https://www.proquest.com/docview/3175401435 https://www.proquest.com/docview/3172777585 https://doaj.org/article/75f7d2ebc13f4e36841d874bc5c30b77 |
| Volume | 25 |
| WOSCitedRecordID | wos001435005600003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMedCentral customDbUrl: eissn: 1471-2407 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017808 issn: 1471-2407 databaseCode: RBZ dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1471-2407 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017808 issn: 1471-2407 databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1471-2407 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017808 issn: 1471-2407 databaseCode: M~E dateStart: 20010101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1471-2407 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017808 issn: 1471-2407 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1471-2407 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017808 issn: 1471-2407 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content Database customDbUrl: eissn: 1471-2407 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017808 issn: 1471-2407 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: Springer LINK customDbUrl: eissn: 1471-2407 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017808 issn: 1471-2407 databaseCode: RSV dateStart: 20011201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEF7RFKFeeJSXoYQFIXEAq_b6sTYX1KBW9JAoSgGF02ofdtRD7GInSBF_npn1OiUguHCJ5Owksj3PnZ35hpBXCrQv4aBpRpvIj5mRoFKq9KNIM6kiC_Jmh03wySSbz_OpS7i1rqyyt4nWUJtaY478GP1cjGB0yfurbz5OjcLTVTdCY4_sI1JZPCD7o9PJdLY9R-BZkPWtMll63II1zrAjOfFDhK7zNzvuyKL2_2mbf3FOv52WWid0dud_b_8uue3CT3rSycs9cqOoDsmtsTtgPyQHGHx22M33yY8RVrXTZbECScFe5ZbCA2Cen0LYSLtSEFqXdLFe0eVlB-m0krSuaD93BewHhLRAvmnqS0M1yljzjko6xtQ7plgoOEtTL107KJUOJOUB-Xx2-unDR98Na_B1kmYrXyslczD8zJRMGSlNaqKs5CmXRQRLhTGMm5DJQBse5FGhJFOJCZVJWFKWYRk9JIOqrorHhOYm0CWEZWD_0hjiFVkEBsMU2BrlTMvYI296nomrDpND2L1MloqOwwI4LCyHxcYjI2TrlhLxtO0XdbMQTj0FT0puWKF0GJVxEaVZHJqMx0onOgoU5x55jkIhuubUrVUQJxnLcaJAknvkpaVATI0Ki3YWct224vxitkP02hGV9aqRWroeCHhuhOHaoTzaoQSl17vLvZgJZ3RacS1jHnmxXcZfYiFdVdRrS8M4x02iRx51Ur19MzEGdBDye-RtL-bXf_73F_zk3_fylBwwVDgLA3BEBqtmXTwjN_V3kOZmSPb4nNvPbOiUd2jzInA1PR9Pv8LV7OLLT-wlTsc |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VFEEvPMrLUOiCQBzAarx-7BoJoRaoGrWJKlqkclrWu3bUQ-wSO6CI_8RvZMaPlIDg1gPXeGIl62--nfHOfAPwNEHvCwV6mjXWdwNuNbpUkrm-b7hO_FrkrR42IUYjeXISH67Aj64XhsoqO06sidoWht6Rb9E-F5AYXfjm7ItLU6PodLUbodHAYj-df8OUrXw9eIfP9xnnu--P3-657VQB14SRrFyTJDpGhuI244nV2kbWl5mIhE59vJRay4X1uO4bKzDdTxPNk9B6iQ15mGVe5uN9L8FqgGCXPVg9HAwPPy3OLYTsy641R0ZbJbK_pA7o0PVIKs-dL21_9ZSAP_eCXzbD305n601v9_r_tlw34FobXrPtxh9uwkqar8OVYVtAsA5rFFw32tS34PsOVe2zSVqhJ1Avdslwwegcg2FYzJpSF1ZkbDyr2OS0kayqNCty1s2VQX7EkB3N59Pi1DJDPjR9xTQb0tECvUJiGAzYYtK2uzLdisDcho8Xsg53oJcXeXoPWGz7JsOwE_k9CjAe02nfUhiGqV_MjQ4ceNFhRJ01miOqztVkpBpEKUSUqhGl5g7sEIwWlqQXXn9QTMeqpR8lwkxYnibG87Mg9SMZeFaKIDGh8fuJEA5sEghV03y7YD21LXlMExPC2IEntQVphuRUlDTWs7JUg6MPS0bPW6OsqKba6LbHA_83yYwtWW4sWSKpmeXLHaxVS6qlOse0A48Xl-mbVCiYp8WstuFCUBLswN3GixYrE1DAiimNAy87tzq_-d8X-P6_f8smXN07Hh6og8Fo_wGscXL2WvJgA3rVdJY-hMvmKyJ7-qglCwafL9rhfgJ5n60D |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagoIpLedNAoQYhcYCoiZ3EDrcWWFFBVxUF1Jvl52oPm1RJFmnFn8fjJEuXxwFxjSdRMpkZf7ZnvkHoufLelzPvaUYbGmfESO9SysWUaiIVDSRvodkEm075-Xl5eqmKP2S7j0eSfU0DsDRV3cGFcb2L8-Kg9VGVQ2VxHqdAQRevrqJrGTQNgvX62df1OQLjCR9LZf5438Z0FFj7f4_NlyanX05LwyQ0ufn_r38L7QwAFB_2FnMbXbHVHbR9Mhyx30XfjyCVHS9s580DCpRb7N8aNvexx4q4z__AtcOzZYcX857HqZO4rvDYbMUHDY9jvfiqqecGazCs5jWW-AT222FfBfsZ0tSLoQYUy4EZ5R76Mnn3-c37eOjQEOu84F2slZKlj_bEOKKMlKYwlDtWMGmpH7LGEGZSIhNtWFJSqyRRuUmVyUnuXOrofbRV1ZXdRbg0iXYei_mgV2QepEibGMAmfj1UEi2zCL0cf5S46Ik4RFjA8EL0-hRenyLoU6widAT_ci0JJNrhQt3MxOCTguWOGWKVTqnLLC14lhrOMqVzTRPFWIT2wRJEX5G6DgXikJMS2gjkZYSeBQkg0qggU2cml20rjs8-bQi9GIRc3TVSy6HwwX83cG9tSO5tSHpP15vDo0mKIdK0AvBfBiSNeYSerofhTsieq2y9DDKEMVgZRuhBb8przWSA4jzOj9Cr0W5_PvzvCn74b-L7aPv07UR8PJ5-eIRuELD8QAuwh7a6Zmkfo-v6WzdvmyfBfX8A4YNGlg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Blood+metabolites+reflect+the+effect+of+gut+microbiota+on+differentiated+thyroid+cancer%3A+a+Mendelian+randomization+analysis&rft.jtitle=BMC+cancer&rft.au=Zhang%2C+Hanfei&rft.au=Li%2C+Yuhao&rft.au=Li%2C+Lin&rft.date=2025-02-28&rft.pub=Springer+Nature+B.V&rft.eissn=1471-2407&rft.volume=25&rft.spage=1&rft_id=info:doi/10.1186%2Fs12885-025-13598-y |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2407&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2407&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2407&client=summon |